...
首页> 外文期刊>European respiratory review >C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis
【24h】

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis

机译:C反应蛋白水平预测COPD死亡率:系统评价和荟萃分析

获取原文

摘要

The prognostic role of baseline C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) is controversial. In order to clarify this issue; we performed a systematic review and meta-analysis to assess the predictive effect of baseline CRP level in COPD patients. 15 eligible articles focusing on late mortality in COPD were included in our study. We performed a random-effects meta-analysis; and assessed heterogeneity and publication bias. We pooled hazard ratio (HR) estimates and their 95% confidence intervals on mortality for the comparison between the study-specific highest category of CRP level versus the lowest category. In overall analysis; elevated baseline CRP levels were significantly associated with higher mortality (HR 1.53; 95% CI 1.32xe2x80x931.77; I2=68.7%; p<0.001). Similar results were observed across subgroups. However; higher mortality risk was reported in studies using a cut-off value of 3xe2x80x85mgxc2xb7Lxe2x88x921 (HR 1.61; 95% CI 1.12xe2x80x932.30) and in those enrolling an Asiatic population (HR 3.51; 95% CI 1.69xe2x80x937.31). Our analysis indicates that baseline high CRP level is significantly associated with higher late mortality in patients with COPD. Further prospective controlled studies are needed to confirm these data.
机译:基线C反应蛋白(CRP)在慢性阻塞性肺疾病(COPD)中的预后作用是有争议的。为了澄清这个问题;我们进行了系统的回顾和荟萃分析,以评估基线CRP水平在COPD患者中的预测效果。我们的研究包括15篇关于COPD晚期死亡率的合格文​​章。我们进行了随机效应荟萃分析;并评估了异质性和发布偏见。我们汇总了危险比(HR)估计值及其对死亡率的95%置信区间,以比较研究特定的CRP最高类别和最低类别。总体分析;基线CRP水平升高与死亡率升高显着相关(HR 1.53; 95%CI 1.32xe2x80x931.77; I2 = 68.7%; p <0.001)。在各亚组中观察到相似的结果。然而;在使用3xe2x80x85mgxc2xb7Lxe2x88x921(HR 1.61; 95%CI 1.12xe2x80x932.30)的临界值的研究以及在亚洲人群中登记的人群中(HR 3.51; 95%CI 1.69xe2x80x937.31)报告了更高的死亡风险。我们的分析表明,基线高CRP水平与COPD患者较高的晚期死亡率显着相关。需要进一步的前瞻性对照研究来确认这些数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号